CIK: 1700969 - Address: 210 East Grand Avenue, South San Francisco, CA 94080
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/15/22 17:40
8/11/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS.m-25116.750-15-6218D
8/15/22 17:12
8/11/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS.m-25116.750-15-6218D
6/23/22 16:40
6/22/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS-11811.760-10-4233D
9/9/21 17:32
9/9/21
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS-12825.540-5-2221D
8/23/21 16:22
8/20/21
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS-23523.470-10-4226D
6/11/21 17:48
6/9/21
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADS.d-25025.050-10-4236D
10/17/18 17:32
10/15/18
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagWitte Owen N.CADP.d27018.000157236D
6/26/17 19:55
6/23/17
KITEKite Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagWitte Owen N.CADM.d22518.000132076D
6/26/17 19:55
6/23/17
KITEKite Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagWitte Owen N.CADS.dm-2,508100.300-25-2576D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact